This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Summary: "Comparative Review of Toxicities and Their Management With Bispecific Agents in MM and B-Cell NHL"

282 views
June 7, 2024

Chapters

Introduction & Recommended Consensus Guidelines

00:00

FDA-Approved Bispecific Agents & Targets

01:11

Managing Cytokine Release Syndrome (CRS)

01:38

Tumor Flare & Injection Site Reactions

04:53

Cytopenias, Infections & Vaccination Strategies

06:40

Neurotoxicity & GPRC5D-Specific Toxicities

11:13

Patient Case Study & Take-Home Messages

14:56

Comments 0
Login to view comments. Click here to Login